Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
基本信息
- 批准号:10029562
- 负责人:
- 金额:$ 44.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdoptionAnatomyAnimal Cancer ModelAnimal ModelAnimalsBreastBreast Cancer ModelBreast Cancer PatientBreast Cancer therapyCalibrationCancer DetectionCell DeathClassificationClinicClinicalClinical ResearchClipCosmeticsDataDiagnosisDiagnosticFemaleGoldHumanImaging TechniquesIn SituIn complete remissionLongitudinal StudiesMagnetic Resonance ImagingMalignant NeoplasmsMammographyMedicalMonitorNeoadjuvant TherapyNorth AmericaOperative Surgical ProceduresOutcomePathologicPatientsPhysical assessmentProceduresProcessPropertyRadiation therapyRadiology SpecialtyRecurrenceResearchResidual CancersRoentgen RaysShapesSignal TransductionSurgeonTechniquesTechnologyTestingTimeTissuesTitaniumTranslatingUltrasonicsUltrasonographyWomanadvanced breast cancerattenuationbasechemotherapyclinical imagingelectric impedancehormone therapyhuman studyimprovedin vivomalignant breast neoplasmnovelpredicting responsequantitative ultrasoundresponsestandard caretooltransmission processtreatment responderstreatment responsetumor
项目摘要
Project Summary
Radiological markers or clips are an essential diagnostic and surgical tool. Radiological clips made of titanium
or gold are widely used, compatible with MRI and have proven safe for use in human patients. These clips come
in many shapes and sizes and are visible with both X-ray and ultrasound. The clips provide large ultrasonic
scattering signals because they are made of gold or titanium, which have large impedance mismatch with tissue.
For example, patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy have
clips placed in the tumors so that surgeons can locate and excise, with accuracy, residual cancer tissue.
Over the last fifteen years, we have been developing quantitative ultrasound (QUS) imaging techniques for
a number of applications including monitoring of therapy response. We have demonstrated that QUS techniques
can detect the response of tumors to therapy because QUS is sensitive to the presence of cell death. Recently,
we were able to implement this approach in a small clinical study, where we demonstrated the ability of QUS to
definitively detect and predict the response of LABC patients to chemotherapy between one and four weeks from
therapy onset. We verified that QUS could identify LABC therapy responders and nonresponders.
However, we hypothesize that accuracies of QUS estimates in humans can be dramatically improved by
incorporating a novel calibration procedure that utilizes appropriate radiological clips as an in situ calibration
target. Clinically, these clips are already being placed in tumors for various diagnostic tasks. By inserting an
appropriate type of clip, the clip can be used as an in situ calibration providing a reference signal for QUS
estimates. The in situ reference will automatically correct for attenuation and transmission losses from overlying
tissue layers. Current reference phantom techniques are incomplete in providing corrections for attenuation and
transmission losses. Therefore, the use of appropriate radiological clips as calibration targets will provides
superior bias and variance of QUS estimates resulting in improved accuracy for identifying LABC response.
The scientific premise of the proposed research is that radiological markers used for X-ray and conventional
ultrasound can also be used as an in situ calibration target for improving QUS estimates in vivo. Novel calibration
procedures will be tested and refined in phantom studies, in animals models of cancer and finally validated in
human breast cancer patients undergoing neoadjuvant chemotherapy using QUS to identify early responders to
therapy. To verify this scientific premise we propose three specific aims. 1) Develop and refine an in situ
calibration approach in phantom studies that accounts for layering effects on QUS estimates thereby improving
QUS estimate accuracy. 2) Validate the in situ calibration approach in animal models of cancer and quantify
calibration properties in a longitudinal study. 3) Collect longitudinal QUS patient data at early time points during
the course of neoadjuvant chemotherapy using a novel in situ calibration procedure and quantify the
improvements of QUS classifier accuracy with the in situ calibration approach.
项目概要
放射标记或夹子是重要的诊断和手术工具。钛制成的放射夹
或金被广泛使用,与 MRI 兼容,并已被证明可安全用于人类患者。这些剪辑来了
有多种形状和尺寸,并且通过 X 射线和超声波都可以看到。夹子提供大超声波
散射信号,因为它们是由金或钛制成的,与组织有很大的阻抗不匹配。
例如,接受新辅助化疗的局部晚期乳腺癌(LABC)患者
将夹子放置在肿瘤中,以便外科医生能够准确定位并切除残留的癌组织。
在过去的十五年里,我们一直在开发定量超声 (QUS) 成像技术
许多应用,包括监测治疗反应。我们已经证明了 QUS 技术
可以检测肿瘤对治疗的反应,因为 QUS 对细胞死亡的存在很敏感。最近,
我们能够在一项小型临床研究中实施这种方法,我们证明了 QUS 的能力
明确检测并预测 LABC 患者对化疗一到四周内的反应
治疗开始。我们验证了 QUS 可以识别 LABC 治疗有反应者和无反应者。
然而,我们假设人类 QUS 估计的准确性可以通过以下方式显着提高:
纳入一种新颖的校准程序,利用适当的放射夹作为原位校准
目标。在临床上,这些夹子已经被放置在肿瘤中以执行各种诊断任务。通过插入一个
适当类型的夹子,该夹子可用作现场校准,为 QUS 提供参考信号
估计。现场参考将自动校正叠加造成的衰减和传输损耗
组织层。当前的参考模型技术在提供衰减校正方面并不完整,并且
传输损耗。因此,使用适当的放射夹作为校准目标将提供
QUS 估计值的优越偏差和方差提高了识别 LABC 响应的准确性。
拟议研究的科学前提是用于 X 射线和常规的放射性标记
超声还可用作原位校准目标,以改善体内 QUS 估计。新颖的校准
程序将在模型研究、癌症动物模型中进行测试和完善,并最终在
接受新辅助化疗的人类乳腺癌患者使用 QUS 来识别早期反应者
治疗。为了验证这一科学前提,我们提出了三个具体目标。 1) 开发和完善现场
模型研究中的校准方法考虑了 QUS 估计的分层效应,从而改进
QUS 估计精度。 2) 在癌症动物模型中验证原位校准方法并进行量化
纵向研究中的校准特性。 3) 在早期时间点收集纵向 QUS 患者数据
使用新型原位校准程序来评估新辅助化疗的过程并量化
通过原位校准方法提高了 QUS 分类器的精度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael L. Oelze其他文献
Detection and localization of small metastatic foci in human lymph nodes using three-dimensional high-frequency quantitative ultrasound methods
使用三维高频定量超声方法检测和定位人体淋巴结中的小转移灶
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Jonathan Mamou;Emi Saegusa-Beecroft;Alain Coron;Michael L. Oelze;Masaki Hata;Junji Machi;Eugene Yanagihara;Pascal Laugier;Tadashi Yamaguchi;Ernest J. Feleppa - 通讯作者:
Ernest J. Feleppa
Low-frequency sound wave parameter measurement in gravels
- DOI:
10.1016/j.apacoust.2009.07.003 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
George W. Swenson;Michael J. White;Michael L. Oelze - 通讯作者:
Michael L. Oelze
Michael L. Oelze的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael L. Oelze', 18)}}的其他基金
2022 In Vivo Ultrasound Imaging Gordon Research Conference
2022 体内超声成像戈登研究会议
- 批准号:
10535954 - 财政年份:2022
- 资助金额:
$ 44.49万 - 项目类别:
Development of radiological clips having ultrasound identification
具有超声识别功能的放射线夹的研制
- 批准号:
10493425 - 财政年份:2021
- 资助金额:
$ 44.49万 - 项目类别:
Development of radiological clips having ultrasound identification
具有超声识别功能的放射线夹的研制
- 批准号:
10365578 - 财政年份:2021
- 资助金额:
$ 44.49万 - 项目类别:
Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
- 批准号:
10202531 - 财政年份:2020
- 资助金额:
$ 44.49万 - 项目类别:
Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
- 批准号:
10615670 - 财政年份:2020
- 资助金额:
$ 44.49万 - 项目类别:
Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
- 批准号:
10400728 - 财政年份:2020
- 资助金额:
$ 44.49万 - 项目类别:
Development of super resolution ultrasound for detecting microcalcifications
开发用于检测微钙化的超分辨率超声
- 批准号:
9767772 - 财政年份:2018
- 资助金额:
$ 44.49万 - 项目类别:
Focused ultrasound therapy for remitting the symptoms of MS in a rat model
聚焦超声疗法可缓解大鼠模型中的多发性硬化症症状
- 批准号:
9454946 - 财政年份:2017
- 资助金额:
$ 44.49万 - 项目类别:
High speed ultrasonic communications for implanted medical devices
用于植入医疗设备的高速超声波通信
- 批准号:
9434036 - 财政年份:2017
- 资助金额:
$ 44.49万 - 项目类别:
Detection and Grading of Fatty and Fibrotic Liver Using Quantitative Ultrasound
使用定量超声检测脂肪肝和纤维化肝并对其进行分级
- 批准号:
9142321 - 财政年份:2015
- 资助金额:
$ 44.49万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 44.49万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 44.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 44.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 44.49万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 44.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 44.49万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 44.49万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 44.49万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 44.49万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 44.49万 - 项目类别:
Standard Grant